Skip to main content
Log in

Receptor blocking drugs and amphetamine anorexia in human subjects

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The interaction between the receptor antagonist thymoxamine (THYM), propranolol (PPL) and metergoline (MTG) with dexamphetamine (d-Amp)-induced anorexia was examined in a series of studies in normal female volunteers. Visual analogue scale (VAS) ratings of hunger were made and food intake was measured using an automated solid food dispenser (AFD). d-Amp (10 mg) significantly depressed hunger ratings compared to placebo in two of the three studies and its effect was countered by the addition of MTG (4 mg). d-Amp significantly reduced food intake compared to placebo in two studies. In all trials the reduction in food intake following d-Amp was significantly greater than would have been predicted from its effect on hunger. THYM (160 mg) and PPL (40 mg) were associated with no changes in food intake when given alone or with d-Amp, MTG increased food intake (but not significantly) and the combined effects of MTG and d-Amp was the algebraic sum of the effect of each; but there appeared to be no true pharmacological interaction between blocker and anorectic. The results indicated that there may be some dissociation between the effect of d-Amp on hunger and food intake but have failed to produce evidence that noradrenergic pathways are involved. The results are consistent with the theories that d-Amp anorexia does not involve the release of 5-hydroxytryptamine (5-HT) but that 5-HT pathways are involved in the feeding process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aitken RCB (1969) Measurement of feelings using visual analogue scales. Proc R Soc Med 62:989–993

    Google Scholar 

  • Besser GM, Butler PWP, Ratcliffe JG, Lees LR, Young P (1968) Release by amphetamine in man of growth hormone and corticosteroids: the effects of thymoxamine and propranolol. Br J Pharmacol 39:196P–197P

    Google Scholar 

  • Blundell JE, Latham CJ (1980) Characterisation of adjustments to the structure of feeding behaviour following pharmacological treatment: effects of amphetamine and fenfluramine and the antagonism produced by pimozide and metergoline. Pharmacol Biochem Behav 12:717–722

    Google Scholar 

  • Blundell JE, Rogers PJ (1980) Effects of anorexic drugs on food intake, food selection and preferences and hunger motivation and subjective experiences. Appetite 1:151–165

    Google Scholar 

  • Borsini F, Bendotti C, Thurlby P, Samanin R (1982) Evidence that systemically administered salbutamol reduces food intake in rats by acting on central beta-adrenergic sites. Life Sci 30 (II):905–911

    Google Scholar 

  • Bryan PC, Efiong DO, Stewart-Jones J, Turner P (1974) Propranalol on tests of visual function and central nervous activity. Br J Clin Pharmacol 1:82–84

    Google Scholar 

  • Burridge SL, Blundell JE (1979) Amphetamine anorexia: antagonism by typical but not atypical neuroleptics. Neuropharmacology 18:453–457

    Google Scholar 

  • Carlsson A (1970) Amphetamines and brain catecholamines. In: Costa E, Garattini S (eds) Amphetamines and related compounds. Raven, New York, pp 289–300

    Google Scholar 

  • Clineschmidt BV, McGuffin JC, Werner AB (1974) Role of monoamines in the anorexigenic actions of fenfluramine, amphetamine and p-chloromethamphetamine. Eur J Pharmacol 27:313–323

    Google Scholar 

  • Delitala G, Masala A, Alagna S, Devilla L, Rovasio PP (1977) Inhibition of prolactin release by metergoline administration in man. Biomedicine 27:31–33

    Google Scholar 

  • Dobrzanski S, Doggett NS (1979) The effect of propranolol, phentolamine and pimozide on drug-induced anorexia in the mouse. Psychopharmacology 66:297–300

    Google Scholar 

  • Ryan JA, Joiner BL, Ryan BF (1976) Minitab Students Handbook, Duxbury, Boston

    Google Scholar 

  • Sanghvi IS, Singer G, Friedman E, Gershon S (1975) Anorexigenic effects of d-amphetamine and L-dopa in the rat. Pharmacol Biochem Behav 3:81–86

    CAS  PubMed  Google Scholar 

  • Silverstone T, Fincham J, Brydon J (1980a) A new technique for the continuous measurement of food intake in man. Am J Clin Nutr 3:1852–1855

    Google Scholar 

  • Silverstone T, Fincham J, Wells B, Kyriakides M (1980b) The effect of the dopamine receptor blocking drug pimozide on the stimulant and anorectic actions of dextroamphetamine in man. Neuropharmacology 19:1235–1237

    Google Scholar 

  • Silverstone T, Kyriakides M (1982) Clinical pharmacology of appetite. In: Silverstone T (ed) Drugs and appetite. Academic, London, pp 93–124

    Google Scholar 

  • Silverstone T, Stunkard AJ (1968) The anorectic effect of dexamphetamine sulphate. Br J Pharmacol Chemother 33:513–522

    Google Scholar 

  • Turner P, Richens A (1982) Clinical Pharmacology, Churchill Livingston, Edinburgh

    Google Scholar 

  • Winn P, Williams SF, Herberg LJ (1982) Feeding stimulated by very low doses of d-amphetamine administered systemically or by microinjection in the striatum. Psychopharmacology 78:336–341

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goodall, E., Trenchard, E. & Silverstone, T. Receptor blocking drugs and amphetamine anorexia in human subjects. Psychopharmacology 92, 484–490 (1987). https://doi.org/10.1007/BF00176483

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00176483

Key words

Navigation